Future challenges for drug delivery

Journal of Controlled Release

Volumn 62, Issue 1-2, 1999, Pages 3-6

  Breimer, D D ^a  

^a LEIDEN UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG DELIVERY SYSTEM; DRUG INDUSTRY; DRUG RESEARCH; DRUG TARGETING; PRIORITY JOURNAL; REVIEW;

EID: 0032851914     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-3659(99)00060-7     Document Type: Note

References (10)

1. Florence A.T. Advances in drug delivery and targeting. The Drug Delivery Companies Report 1996/97, CONNECT Pharma Reports. 1996;17-27 CONNECT Pharma, Oxford, UK.
2. Guy R.H., Powell M., Fix J., Park K. Controlled release technologies: current status and future prospects. Pharm. Res. 13:1996;1759-1785.
3. Sam T., Fokkens J. Innovations in Drug Delivery. Impact on pharmacotherapy. 1996;The Anselmus Foundation, Houten, The Netherlands.
4. Hambrecht and Quist Inc. List of Major Pharmaceutical Products Using Drug Delivery. 1997.
5. Powers Cramer M., Saks S.R. Translating safety, efficacy and compliance into economic value for controlled release dosage forms. Pharmacoeconomics. 5:1994;482-504.
6. Breimer D.D. An integrated pharmacokinetic and pharmacodynamic approach to controlled drug delivery. J. Drug Target. 3:1996;411-415.
7. Kleinbloesem C.H., van Brummelen P., Danhof M., Faber H., Urquhart J., Breimer D.D. Rate of increase in plasma concentration of nifedipine as a major determinant of its haemodynamic effects in humans. Clin. Pharmacol. Ther. 41:1987;26-30.
8. Breimer D.D. The need for rate and time programming in future drug delivery. Pharmacokinetic, pharmacodynamic and clinical considerations. Gurny R., Junginger H.E., Peppas N.A. Pulsatile Drug Delivery Current Applications and Future Trends. 1994;25-40 Wiss. Verlagsgesellschaft, Stuttgart, Germany.
9. Nature, Supplement to Volume 384 (November 7) (1996) 1-26.
10. Wang W. Oral Protein Drug Delivery. J. Drug Target. 4:1996;195-232.